Local Infusion will expand its infusion offerings with the addition of QIVIGY® (Immune Globulin Intravenous, human-kthm) 10% liquid from Kedrion Biopharma
NASHVILLE, Tenn. — Local Infusion, the fastest growing ambulatory infusion provider in the United States, today announced it is joining Kedrion Biopharma’s limited distribution network for QIVIGY (immune globulin intravenous, human-kthm), a 10% intravenous immunoglobulin (IVIG) solution to treat adults with Primary Humoral Immunodeficiency (PI).
QIVIGY was approved by the FDA in late 2025 and will be available for use in March 2026, giving patients a new option to replace deficient antibodies and reduce infection rates.
Kedrion Biopharma selected Local Infusion for its unique capability to bring together infusion data, intelligent automation, and programmable care pathways to help patients get treated quicker, improve treatment adherence, and ultimately deliver better patient outcomes.
“At Kedrion, our dedication to those affected by rare diseases drives everything we do,” said Lynda Bowe, Vice President Corporate Accounts of Kedrion. “Working with Local Infusion, we are united in our goal to make QIVIGY available to more people living with Primary Humoral Immunodeficiency across more communities. Together, we can help ensure that patients get the therapies they need more conveniently and reliably.”
“Kedrion’s decision to name Local Infusion as the first Ambulatory Infusion Center in its limited distribution network for QIVIGY is a testament to the high quality of care our patients receive,” said Ashley Knapp, Co-Founder and Chief of Staff at Local Infusion. “Through this limited distribution network, patients receiving QIVIGY have a convenient, comfortable option that gets them to treatment faster.”
By joining the QIVIGY limited distribution network, Local Infusion continues to expand its patient-centered programs accelerating speed to treatment and patient outcomes in collaboration with manufacturers, healthcare providers, health systems, and payors nationwide.
About Local Infusion
Local Infusion is a leading health care and technology company dedicated to transforming the specialty infusion industry, because patients deserve better. By combining comfortable, patient-centered clinical care with a proprietary, AI-driven technology platform, Local Infusion accelerates access, simplifies workflows, and improves outcomes for everyone in the infusion journey — from patients and clinicians to health plans, health systems, employers, and pharma. With Local Infusion, every patient and every care team is fully supported, every step of the way. Learn more at www.mylocalinfusion.com.
Local Infusion Media Contact
Riley Steinmetz
VP of Marketing
[email protected]
